Who backs ONL Therapeutics?
26 investors| Investor | Type |
|---|---|
| National Institutes of Health | Other |
| Johnson & Johnson JJDC | Venture capital |
| Innovation Partnerships | Venture capital |
| Novartis Venture Fund | Other |
| University of Michigan Endowment | Other |
| PSQ Capital | Family office |
| Bios Partners | — |
| Biosciences Research and Commercialization Center | — |
| Capital Community Angels Investors | — |
| ExSight Ventures | — |
| + 16 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
ONL Therapeutics investors
26 investors are on record for ONL Therapeutics, including National Institutes of Health, Johnson & Johnson JJDC, Innovation Partnerships and Novartis Venture Fund. The later-stage round in Sep 2024 drew 35 investors.
Free account
More of ONL Therapeutics with a free account
- ·The complete investor list: 26 names
- ·Watch ONL Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 26 firms already write checks for companies like ONL Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View